Abstract
The kidney is a target for toxicants including cisplatin and S-(1,2-dichlorovinyl)-L-cysteine (DCVC), a metabolite of the environmental contaminant, trichloroethylene. Necrosis is well characterized in kidney cells, but pathways leading to apoptosis are less clear. Cysteine conjugates are useful toxicants because they induce either necrosis or apoptosis depending on chemical structure or antioxidant status. Herein, we show that in the renal epithelial cell line LLC-PK1, activation of caspase-3 (CPP32/Yama/apopain) is crucial for apoptosis, but not necrosis. Apoptosis was blocked by zVAD.fmk, and partially by a cathepsin inhibitor. Caspase-3 activity and cleavage of poly(ADP-ribose) polymerase (PARP) was detected only during apoptosis. S-(1,1,2,2-Tetrafluoroethyl)-L-cysteine (TFEC), a metabolite of tetrafluoroethylene, kills cells only by necrosis, and did not activate caspases under any conditions. Apoptosis and activation of caspase-3 by cisplatin, but not DCVC, was prevented by bcl-2. Thus, caspase-3 activation by bcl-2-dependent and -independent mechanisms is a terminal event in chemical-apoptosis of renal epithelial cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- DCVC:
-
S-(1,2-dichlorovinyl)-L-cysteine
- DMEM:
-
Dulbecco's modified Eagles's medium
- DPPD:
-
N,N′-phenyl-p-phenylenediamine
- LDH:
-
lactate dehydrogenase
- PARP:
-
poly(ADP-ribose) polymerase
- pkBcl-2:
-
cells transfected with a bcl-2 expression vector and selected for neomycin resistance
- pkNEO:
-
cells transfected with a neomycin resistance marker only
- TFEC:
-
S-(1,1,2,2-tetrafluoroethyl)-L-cysteine
References
Adams JM and Cory S. . 1998 Science 281: 1323–1326.
Antoku K, Liu Z and Johnson DE. . 1997 Leukemia 11: 1665–1672.
Ashkenazi A and Dixit VM. . 1998 Science 281: 1305–1308.
Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M and Hanada K. . 1982 Biochem. J. 201: 189–198.
Bissonnette RP, Echeverri F, Mahboubi A and Green DR. . 1992 Nature 359: 552–554.
Bonfoco E, Krainc D, Ankarcrona M, Nicotera P and Lipton SA. . 1995 Proc. Natl. Acad. Sci. USA 92: 7162–7166.
Brunk UT, Dalen H, Roberg K and Hellquist HB. . 1997 Free Radic. Biol. Med. 23: 616–626.
Buttke TM and Sandstrom PA. . 1994 Immunol. Today 15: 7–10.
Chen Q, Jones TW, Brown PC and Stevens JL. . 1990 J. Biol. Chem. 265: 21603–21611.
Cohen GM. . 1997 Biochem. J. 326: 1–16.
Cronin RE and Henrich WL. . 1995 In: The Kidney. Brenner BM. (ed.) W.B. Saunders: Philadelphia. pp. 1680–1711.
Darmon AJ, Ley TJ, Nicholson DW and Bleackley RC. . 1996 J. Biol. Chem. 271: 21709–21712.
Datta R, Kojima H, Banach D, Bump NJ, Talanian RV, Alnemri ES, Weichselbaum RR, Wong WW and Kufe DW. . 1997 J. Biol. Chem. 272: 1965–1969.
Deiss LP, Galinka H, Berissi H, Cohen O and Kimchi A. . 1996 EMBO J. 15: 3861–3870.
Distelhorst CW, Lam M and McCormick TS. . 1996 Oncogene 12: 2051–2055.
Edelstein CL, Ling H and Schrier RW. . 1997 Kid. Int. 51: 1341–1351.
Eguchi Y, Shimizu S and Tsujimoto Y. . 1997 Cancer Res. 57: 1835–1840.
Emoto Y, Manome Y, Meinhardt G, Kisaki H, Wong WW, Kamen R, Weichselbaum R and Kufe D. . 1995 EMBO J. 14: 6148–6156.
Evan G and Littlewood T. . 1998 Science 281: 1317–1322.
Fanidi A, Harrington EA and Evan GI. . 1992 Nature 359: 554–556.
Goldstein RS and Schnellmann RG. . 1996 In: Toxicology, Klaassen CD . (ed.). McGraw-Hill: New York. pp. 417–442.
Green DR and Reed JC. . 1998 Science 281: 1309–1312.
Gregoli PA and Bondurant MC. . 1999 J. Cell Physiol. 178: 133–143.
Guenette RS, Mooibroek M, Wong K, Wong P and Tenniswood M. . 1994 Eur. J. Biochem. 226: 311–321.
Jacobson MD. . 1996 Trends. Biochem. Sci. 21: 83–86.
Kane DJ, Ord T, Anton R and Bredesen DE. . 1995 J. Neurosci. Res. 40: 269–275.
Kayaga S, Kitanaka C, Noguchi K, Mochizuki T, Sugiyama A, Asai A, Yasuhara N, Eguchi Y, Tsujimoto Y and Kuchino Y. . 1997 Mol. Cell. Biol. 17: 6763–6765.
Kerr JFR, Wyllie AH and Currie AR. . 1972 Br. J. Cancer 26: 239–257.
Kroemer G. . 1997 Nature Med. 3: 614–620.
Leist M, Single B, Castoldi AF, Kuhnle S and Nicotera P. . 1997 J. Exp. Med. 185: 1481–1486.
Lieberthal W and Levine JS. . 1996 Am. J. Physiol. 271: F477–F488.
Lock EA. . 1989 Toxicol. Lett. 46: 93–106.
Lotem J and Sachs L. . 1996 Proc. Natl. Acad. Sci. USA 93: 12507–12512.
Majno G and Joris I. . 1995 Am. J. Pathol. 146: 3–15.
Martin SJ, Amarante-Mendes GP, Shi L, Chuang TH, Casiano CA, O'Brien GA, Fitzgerald P, Tan EM, Bokoch GM, Greenberg AH and Green DR. . 1996 EMBO J. 15: 2407–2416.
Martin SJ and Green DR. . 1995 Cell 82: 349–352.
McGowan AJ, Ruiz-Ruiz MC, Gorman AM, Lopez-Rivas A and Cotter TG. . 1996 FEBS Lett. 392: 299–303.
Moallem SA and Hales BF. . 1995 Teratology 52: 3–14.
Packham G and Cleveland JL. . 1995 Biochim. Biophys. Acta 1242: 11–28.
Reed JC. . 1994 J. Cell. Biol. 124: 1–6.
Reed JC. . 1997 Nature 387: 773–776.
Roberts LR, Kurosawa H, Bronk SF, Fesmier PJ, Agellon LB, Leung WY, Mao F and Gores GJ. . 1997 Gastroenterology 113: 1714–1726.
Shimizu S, Eguchi Y, Kamiike W, Matsuda H and Tsujimoto Y. . 1996 Oncogene 12: 2251–2257.
Simboli-Campbell M, Narvaez CJ, van Weelden K, Tenniswood M and Welsh J. . 1997 Breast Cancer Res. Treat. 42: 31–41.
Stevens JL, Robbins JD and Byrd RA. . 1986 J. Biol. Chem. 261: 15529–15537.
Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M and Kroemer G. . 1996 J. Exp. Med. 184: 1331–1341.
Thornberry NA and Lazebnik Y. . 1998 Science 281: 1313–1316.
Trudel M, Lanoix J, Barisoni L, Blouin M-J, Desforges M, L'Italien C and D'Agati VD. . 1997 J. Exp. Med. 186: 1873–1884.
Vamvakas S, Dekant W and Henschler D. . 1989 Mutat. Res. 222: 329–335.
van de Water B, Kruidering M and Nagelkerke JF. . 1996 Am. J. Physiol. 270: F593–F603.
van de Water B, Nagelkerke JF and Stevens JL. . 1999 J. Biol. Chem. 274: 13328–13337.
van de Water B, Zoeteweij JP, de Bont HJGM, Mulder GJ and Nagelkerke JF. . 1994 J. Biol. Chem. 269: 14546–14552.
Wagner AJ, Small MB and Hay N. . 1993 Mol. Cell Biol. 13: 2432–2440.
Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T-I, Jones DP and Wang X. . 1997 Science 275: 1129–1132.
Zhan Y, Cleveland JL and Stevens JL . 1997 Mol. Cell. Biol. 17: 6755–6764.
Zornig M, Busch G, Beneke R, Gulbins E, Lang F, Ma A, Korsmeyer S and Moroy T. . 1995 Oncogene 11: 2165–2174.
Acknowledgements
These studies were supported by Public Health Service Grants DK46267 and ES07847 to JL Stevens and a Talent Stipend from the Dutch Organization for Scientific Research to B van de Water. The authors thank Dr Don Nicholson for providing the anti-caspase-3 antibody, Sal Morana for reading the manuscript. We also thank JoEllen Welsh and Manjula Donepudi for assistance with the flow cytometery.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhan, Y., van de Water, B., Wang, Y. et al. The roles of caspase-3 and bcl-2 in chemically-induced apoptosis but not necrosis of renal epithelial cells. Oncogene 18, 6505–6512 (1999). https://doi.org/10.1038/sj.onc.1203060
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203060
Keywords
This article is cited by
-
Quantum biological tunnel junction for electron transfer imaging in live cells
Nature Communications (2019)
-
Intradermal delivery of DNA encoding HCV NS3 and perforin elicits robust cell-mediated immunity in mice and pigs
Gene Therapy (2016)
-
Baicalein reduces the occurrence of cirrhotic endotoxemia by reducing intestinal mucosal apoptosis
BMC Complementary and Alternative Medicine (2015)
-
The role of visfatin on the regulation of inflammation and apoptosis in the spleen of LPS-treated rats
Cell and Tissue Research (2015)
-
Sigma receptor 1 modulates ER stress and Bcl2 in murine retina
Cell and Tissue Research (2014)